Blueprint Medicines's total assets for Q4 2024 were $1.18B, a decrease of -1.65% from the previous quarter. BPMC total liabilities were $881.15M for the fiscal quarter, a -0.60% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.